These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
119 related articles for article (PubMed ID: 22293163)
1. Sincalide cholescintigraphy--32 years later: evidence-based data on its clinical utility and infusion methodology. Ziessman HA Semin Nucl Med; 2012 Mar; 42(2):79-83. PubMed ID: 22293163 [TBL] [Abstract][Full Text] [Related]
2. Sincalide: A Review of Clinical Utility, Proper Infusion Methodology, and Alternative Cholecystogogues. Ziessman HA J Nucl Med Technol; 2019 Sep; 47(3):210-212. PubMed ID: 31019045 [TBL] [Abstract][Full Text] [Related]
3. Sincalide-stimulated cholescintigraphy: a multicenter investigation to determine optimal infusion methodology and gallbladder ejection fraction normal values. Ziessman HA; Tulchinsky M; Lavely WC; Gaughan JP; Allen TW; Maru A; Parkman HP; Maurer AH J Nucl Med; 2010 Feb; 51(2):277-81. PubMed ID: 20080900 [TBL] [Abstract][Full Text] [Related]
4. Cholecystokinin cholescintigraphy: victim of its own success? Ziessman HA J Nucl Med; 1999 Dec; 40(12):2038-42. PubMed ID: 10616884 [TBL] [Abstract][Full Text] [Related]
5. Normal values for sincalide cholescintigraphy: comparison of two methods. Ziessman HA; Muenz LR; Agarwal AK; ZaZa AA Radiology; 2001 Nov; 221(2):404-10. PubMed ID: 11687683 [TBL] [Abstract][Full Text] [Related]
14. Estimation of gallbladder ejection fraction utilizing cholecystokinin-stimulated magnetic resonance cholangiography and comparison with hepatobiliary scintigraphy. Vyas PK; Vesy TL; Konez O; Ciavellara DP; Hua K; Gaisie G J Magn Reson Imaging; 2002 Jan; 15(1):75-81. PubMed ID: 11793460 [TBL] [Abstract][Full Text] [Related]
15. Consensus report on standardization of sincalide cholescintigraphy. Ziessman HA; Tulchinsky M; Maurer A J Nucl Med; 2011 Aug; 52(8):16N. PubMed ID: 21810583 [No Abstract] [Full Text] [Related]
16. Diagnosis of BD relied in great measure on gallbladder ejection fraction (GBEF) after sincalide stimulation on hepatobiliary scintigraphy. Tulchinsky M J Pediatr Surg; 2009 Oct; 44(10):2059; author reply 2059-60. PubMed ID: 19853777 [No Abstract] [Full Text] [Related]
17. Effectiveness of cholecystokinin-stimulated cholescintigraphy in the diagnosis and treatment of acalculous gallbladder disease. Mishkind MT; Pruitt RF; Bambini DA; Hakenewerth AM; Thomason MH; Zuger JH; Novick T Am Surg; 1997 Sep; 63(9):769-74. PubMed ID: 9290518 [TBL] [Abstract][Full Text] [Related]
18. Optimum utilization of cholecystokinin cholescintigraphy (CCK-HIDA) in clinical practice: an evidence based review. Richmond BK W V Med J; 2012; 108(2):8-11. PubMed ID: 22655428 [TBL] [Abstract][Full Text] [Related]
19. Chronic Acalculous Cholecystitis in Children With Biliary Symptoms: Usefulness of Hepatocholescintigraphy. Kwatra NS; Nurko S; Stamoulis C; Falone AE; Grant FD; Treves ST J Pediatr Gastroenterol Nutr; 2019 Jan; 68(1):68-73. PubMed ID: 30256266 [TBL] [Abstract][Full Text] [Related]
20. Clinical utility of stimulated cholescintigraphy using a standardized Ensure-Plus fatty meal protocol in patients with suspected functional gallbladder disorder: a retrospective study of seven-years clinical experience. Li AY; Yue H; Kavnoudias H; Cherk MH; Nadebaum DP; Barton H; Beech P; Yap KSK; Smith M; Paul E; Barber TW ANZ J Surg; 2022 Apr; 92(4):774-780. PubMed ID: 34850524 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]